Medicinal use of cannabis based products and cannabinoids
Abstrak
### What you need to know Until recently, cannabis and its derivatives were widely restricted under legislation which stated they had no medical value and carried a substantial risk of misuse. Policy is rapidly changing, and cannabis can now be prescribed for medicinal use in many countries, including the UK. This provides important new opportunities for treating patients although these need to be weighed up against potential risks. Several different medicinal products exist, with contrasting mechanisms of action, efficacy, and safety. Use of these products may increase as new evidence arises and policy changes occur. Here we review this emerging field. In the UK, drugs perceived by policy makers to have no medical value and a high risk of misuse, such as MDMA (3,4-methylenedioxy-methamphetamine, common street name “ecstasy”) are placed in Schedule …
Penulis (4)
T. Freeman
C. Hindocha
S. Green
M. Bloomfield
Akses Cepat
- Tahun Terbit
- 2019
- Bahasa
- en
- Total Sitasi
- 187×
- Sumber Database
- Semantic Scholar
- DOI
- 10.1136/bmj.l1141
- Akses
- Open Access ✓